Results 201 to 210 of about 56,119 (256)

Tear deficiency transforms spatial distribution of corneal calcitonin gene-related peptide-positive nerves in rats. [PDF]

Front Cell Neurosci
Kiyoi T, Nakajima A, He Q, Liu L, Zheng S, Kobayashi S, Uwada J, Masuoka T.   +7 more
europepmc   +1 more source

Comparing the impact of systemic pituitary adenylate-cyclase-activating polypeptide (PACAP) and calcitonin gene-related peptide (CGRP) on motion-induced nausea and balance behaviors in mice. [PDF]

PLoS One
Rahman SM, Dweh A, Luebke AE.
europepmc   +1 more source

Calcitonin Gene-Related Peptide Monoclonal Antibody Treatment in Nine Cases of Persistent Headache Following COVID-19-Infection. [PDF]

J Korean Med Sci
Choi S, Hong Y, Kang MK, Song TJ, Cho SJ.   +4 more
europepmc   +1 more source

Patient Adherence and Long-Term Tolerability of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention: A Systematic Review. [PDF]

Cureus
Ray R, Virk GS, Regmi N, Shafiq MM, Siddique R, Elfatih Elamin A, Jihad Y, Ali A, Devi H, Essani B.   +9 more
europepmc   +1 more source

Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays. [PDF]

Headache
Garelja ML, Rees TA, Hay DL.
europepmc   +1 more source

Ubrogepant, erenumab, and eptinezumab antagonize positive inotropic effects of the calcitonin gene-related peptide in the isolated human atrium. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Neumann J, Hofmann B, Gergs U.
europepmc   +1 more source

Real-world effectiveness of eptinezumab in chronic migraine-increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fog. [PDF]

J Headache Pain
Argoff C, Khan FA, Herzog SP, Smith RM, Soni-Brahmbhatt S, Asher D, Awad SF, Grossman SW, Patel F, Buse DC.   +9 more
europepmc   +1 more source

Neuroimmunology of psoriasis: Possible roles for calcitonin gene-related peptide in its pathogenesis. [PDF]

Brain Behav Immun Health
Kotlyar J, Granstein RD.
europepmc   +1 more source

Injection-Based Therapies for Migraine in Older Adults: A Narrative Review of OnabotulinumtoxinA, Greater Occipital Nerve Block, and Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies. [PDF]

J Korean Med Sci
Kang MK, Cho S, Kim BK, Moon HS, Lee MJ, Kim SK, Park HK, Chu MK, Ha WS, Kim BS, Cho SJ.   +10 more
europepmc   +1 more source